US Patent Issued to Incyte on Feb. 17 for "Topical formulations of ruxolitinib with an organic amine pH adjusting agent for treatment of skin diseases" (British, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,485, issued on Feb. 17, was assigned to Incyte Corp. (Wilmington, Del.).

"Topical formulations of ruxolitinib with an organic amine pH adjusting agent for treatment of skin diseases" was invented by Naresh Modepalli (Wilmington, Del.), Trupti Sheth (Wilmington, Del.), Marc Brown (Guildford, Great Britain), Charles Evans (Guildford, Great Britain), James Fidge (Guildford, Great Britain), Florencia Guidali (Guildford, Great Britain), Tecashanell McIntosh (Guildford, Great Britain) and Vanessa Cofre (Guildford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to topical formulations and methods of treating ski...